Concepedia

Eric Yan

EY

Statistics

Publications

5

Citations

288

H-Index

5

Active since

2011

Affiliations

Pfizer (United States)(Current)

Rabin Medical Center

Jupiter Medical Center

Johns Hopkins University

University of Utah

Eric Yan is an author at Pfizer (United States) specializing in medicine, ophthalmology, and ophthalmic surgery.

Publications per year

2011–2018

5

Publications

5

Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Investigative Ophthalmology & Visual Science · 2012 · 101 citations

, , +16

Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Ophthalmology · 2012 · 82 citations

, , +9

Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia

Hagop M. Kantarjian, Yun Su, Elias Jabbour et al. · Cancer · 2018 · 52 citations · Full text

, , +15

Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study

Tomoko Maeda‐Chubachi, Katherine Chi-Burris, Brad D. Simons et al. · Ophthalmology · 2011 · 42 citations

, , +14

Impact of Age, Diagnosis, and History of Glaucoma Surgery on Outcomes in Pediatric Patients Treated With Latanoprost

Tomoko Maeda‐Chubachi, Katherine Chi-Burris, Brad D. Simons et al. · Journal of Glaucoma · 2013 · 11 citations

, , +17

1–5 of 5